ArticleMedical oncology (Northwood, London, England)2025

Identifying drug targets and evaluating KLK3-targeted inhibitors for prostate cancer using in-silico and in-vitro approaches.

Imran Zafar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.